Also called hypoactive sexual desire disorder
HSDD (hypoactive sexual desire disorder) is a persistent lack of sexual desire causing distress. It is the endpoint for which the melanocortin agonist PT-141 (bremelanotide) was studied and approved.
Research use only. This definition is an educational reference, not medical advice or dosing guidance.